CompoAtlas

Saffron 2020-MAX

Natural health product licensed in Canada

Other names
Saffron 2020-ULTRA, Saffron 2020-XP
Licence holder
Groupe Persavita Inc.
NPN or DIN-HM
80088464
Status
Active licence
Licence date
26 September 2018
Revision date
27 September 2019
Form
Capsule, dur
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Cuivre

Source : Citrate de cuivre (II)

0.6 mg1,200 µg
trans-Resvératrol

Source : Reynoutria Japonica - racine

5 mgNot calculated
trans-Resvératrol

Source : Resvératrol

5 mgNot calculated
Riboflavine

Source : Riboflavine

0.5 mg1,000 µg
Vitamine C

Source : Acide ascorbique

250 mg500,000 µg

Non-medicinal ingredients

Cellulose microcristalline, Hydroxypropylméthylcellulose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule2 days

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density. Antioxidants for the maintenance of eye health. Antioxidants for the maintenance of good health. Provides antioxidants. Helps in wound healing. Helps in connective tissue formation. Helps to maintain immune function. Helps to produce and repair connective tissue. Helps support macular health. Helps in the development and maintenance of bones. Helps in the development and maintenance of cartilage. Helps to maintain the body¿s ability to metabolize nutrients. An eye vitamin/mineral supplement that helps delay progression of Age-Related Macular Degeneration (AMD) and helps maintain healthy vision. Contains Lutein and Zeaxanthin helping to increase serum levels within the body. Lutein also will help increase macular pigment optical density, which reduces the progression of AMD and helps maintain healthy vision. Contains Lutein and Zeaxanthin, which help to reduce the risk of decreased visual acuity associated with advanced age related macular degeneration.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80088464

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2019. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line